Drew, Yvette and Kim, Jae-Weon and Penson, Richard T. and O'Malley, David M. and Parkinson, Christine and Roxburgh, Patricia and Plummer, Ruth and Im, Seock-Ah and Imbimbo, Martina and Ferguson, Michelle and Rosengarten, Ora and Steeghs, Neeltje and Kim, Min Hwan and Gal-Yam, Einav and Tsoref, Daliah and Kim, Jae-Hoon and You, Benoit and De Jonge, Maja and Lalisang, Roy and Gort, Eelke and Bastian, Sara and Meyer, Kassondra and Feeney, Laura and Baker, Nigel and Ah-See, Mei-Lin and Domchek, Susan M. and Banerjee, Susana (2024) Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study. Clinical Cancer Research, 30 (1). pp. 50-62. ISSN 1078-0432